A Medical Device Daily
US Oncology (Houston) reported that it has established US Oncology Clinical Development (USOCD), a full service contract research organization (CRO).
The company said that USOCD formalizes many of the services that US Oncology Research has provided since its inception in 1999. For more than a decade US Oncology Research has offered pharma and biotech companies elements of the clinical trial management process.
USOCD will provide CRO capabilities in the following areas: Phase I clinical trials (inpatient and outpatient, including first in man); Phase II-IV clinical trials; physician advisory boards; safety data collection and regulatory submission; data management (registration desk); biostatistics; medical writing and protocol development; medical monitoring; regulatory document collection and submissions; monitoring and auditing; site selection and payments; central IRB; and true feasibility data.
"We have built an experienced team that enhances our ability to serve our clients for all of their oncology clinical trial needs," said Steve Smith, VP and general manager of Research and Personalized Science at US Oncology.
In other new ventures, Iatric Systems (Boxford, Massachusetts) reported a new division dedicated to strategic integration and interface solutions for the healthcare information systems (HIS) market. The Integration and Interface Services Division will partner with hospitals to help engineer and integrate cost-effective solutions within the entire HIS enterprise.
Iatric Systems solutions are able to interface with more than 650 software systems and platforms. The new division will build on this.
"Our primary goal for this new division is to partner with hospital HIS professionals to identify, engineer and present cost-effective software solutions that integrate seamlessly into their existing infrastructure," said James Lawson, associate vice president of Iatric Systems' new Integration and Interface Services Division.